InvestorsHub Logo
Followers 230
Posts 21500
Boards Moderated 2
Alias Born 08/03/2006

Re: sox040713 post# 222200

Friday, 03/23/2018 7:26:15 PM

Friday, March 23, 2018 7:26:15 PM

Post# of 403254
Nail on the head. Seems to be a lot of confusion. It's really the difference of being on the otc Vs. big boards right now. The inflection point right before real footprints are made.
The battle of whether or not the first deal will be made. Longs vs. shorts. Well, being on the otc certainly helps the shorts since there isn't the opportunity for institutions to get a foothold.
So we rely on our dd. And from where I'm sitting, brilacidin is already a go. Kevetrin has a very impressive green light and the wild card is prurisol which stands up to the competition hands down based on prior data.
And we're close. Why someone would let themselves throw in the towel now just baffles me. It does take time to get full data on the table and decide the best way forward.
It is about risk, and everyone has to measure their own. We're on our own until the first license / partnership goes through.
Just remember, Dr. B is with us for a reason.

Imho

$IPIX

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News